A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: A Gynecologic Oncology Group study

✍ Scribed by James V. Fiorica; John A. Blessing; Louis V. Puneky; Angeles Alvarez Secord; James S. Hoffman; S. Diane Yamada; Thomas E. Buekers; Jeffrey Bell; Jeanne M. Schilder

• Book ID: 113962169
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 142 KB
• Volume: 115
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2009.07.024